Targeting cancer with best-in-class ADCs
Solve Therapeutics is a clinical-stage biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) and bispecific therapeutics targeting cancer. The company focuses on high selectivity and optimized payload delivery to improve outcomes for patients with solid tumors.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountNov 2025
Dec 2024
Dec 2023
Create a free account to see which investors have funded this company.
Create Free Account
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Global biosimulation software and services company accelerating drug development for 2,000+ bioph...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
